INTELLIPHARMACEUTICS INTERNATIONAL INC. Direct Operating Costs
INTELLIPHARMACEUTICS INTERNATIONAL INC. reported Direct Operating Costs of $656.38 thousand for the 12-month period ending 2021-11-30, per its 20-F/A filed 2022-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DirectOperatingCosts · last filed 2022-05-09
| Period end | Direct Operating Costs 12 month |
|---|---|
| 2021-11-30 | $656.38K 20-F/A · filed 2022-05-09 |